- Investing Ideas
- /
- Taiwanese Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
Taiwanese Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
Results
3
0 new
High return on equity, past performance and sound balance sheet.
3 companies
PharmaEngine
Market Cap: NT$10.8b
A biopharmaceutical company, engages in the development of drugs and therapeutic drugs for treating cancer in Taiwan.
4162
NT$75.40
7D
1.9%
1Y
-23.2%
TTY Biopharm
Market Cap: NT$18.6b
Engages in the development and sale of pharmaceutical and chemical drugs in Taiwan and internationally.
4105
NT$74.70
7D
0.4%
1Y
-1.8%
Lotus Pharmaceutical
Market Cap: NT$56.8b
Engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally.
1795
NT$217.00
7D
3.8%
1Y
-25.4%